Home › MolMed TK therapy submitted for Conditional Marketing Authorisation in EU
 

Keywords :   


MolMed TK therapy submitted for Conditional Marketing Authorisation in EU

2014-03-13 21:03:04| Logistics - Topix.net

MolMed S.p.A. announces that the Company has filed to the European Medicines Agency an application for Conditional Marketing Authorisation for TK, its novel investigational cell-gene therapy.

Tags: in marketing submitted therapy

Category:Transportation and Logistics

Latest from this category

All news
23.11Atlantic Tropical Weather Outlook
23.11Eastern North Pacific Tropical Weather Outlook
22.11Eastern North Pacific Tropical Weather Outlook
22.11Atlantic Tropical Weather Outlook
22.11Eastern North Pacific Tropical Weather Outlook
22.11Atlantic Tropical Weather Outlook
22.11Atlantic Tropical Weather Outlook
22.11Eastern North Pacific Tropical Weather Outlook
Transportation and Logistics »
23.11contactglove tundratracker
23.11
23.11RUSSELUNO
23.11C282 800yd IP54
23.11X-FLY4 27.5
23.118
23.11 (1~40)
23.1101DVDBOX
More »